Customize your JAMA Network experience by selecting one or more topics from the list below.
In the News From the Food and Drug Administration item entitled “Generic for Opioid Use Disorder,”1 published in the July 17, 2018, issue of JAMA, an incorrect medication was reported. In the second paragraph, the second sentence should have read as follows: “Buprenorphine, naltrexone, and methadone are FDA-approved to help patients who misuse opioids.” This article was corrected online.
Incorrect Medication Reported. JAMA. 2018;320(9):938. doi:10.1001/jama.2018.11607